Literature DB >> 6760375

The aerobic and anaerobic microflora of the gastric remnant more than 15 years after Billroth II resection.

L K Enander, F Nilsson, A C Rydén, A Schwan.   

Abstract

The bacteriology of the gastric remnant contents was examined in 150 patients 15-20 years after Billroth II resection for duodenal ulcer disease. Samples of gastric contents were aspirated through a gastroscope, and aerobic and anaerobic microflora were cultured and analyzed semiquantitatively. All patients but one had bacterial growth, with a mean number of 6.8 strains per remnant. One third of the bacterial strains were anaerobic, and many of them had their normal habitat in the colon. The role played by bacteria of the gastric remnant in the etiology of mucosal pathology and gastric remnant disease is discussed.

Entities:  

Mesh:

Year:  1982        PMID: 6760375     DOI: 10.3109/00365528209181084

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  A 14-day elemental diet is highly effective in normalizing the lactulose breath test.

Authors:  Mark Pimentel; Tess Constantino; Yuthana Kong; Meera Bajwa; Abolghasem Rezaei; Sandy Park
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

2.  Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.

Authors:  R J Brummer; R W Stockbrügger
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

3.  Duodenal bacterial overgrowth during treatment in outpatients with omeprazole.

Authors:  M Fried; H Siegrist; R Frei; F Froehlich; P Duroux; J Thorens; A Blum; J Bille; J J Gonvers; K Gyr
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

4.  Changes in the Paneth cell population of human small intestine assessed by image analysis of the secretory granule area.

Authors:  M E Elmes; J G Jones; M R Stanton
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.